u/careful_gradient_notes

This is evidence. The metadata is checkable and it is odd.

Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.

the glucagon component changes the side effect profile, not just the efficacy

Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.

retatrutide is not approved anywhere for human use, posts must not read as instructions

a dispute resolves, edit the post and say so

The BCH exit scam collected 6 orders and disappeared. Order ids 24 through 6 all silent.

PDF metadata said the COA was created in a browser four months after the date printed on the page. Worth flagging.

The cloned SGN store used our old homepage image from 2023. Reverse image search caught it in 18 seconds.

Not convinced. The evidence does not support that reading.

Crossposting this to c/semaglutide because the people who need it are not reading this community.

no doxxing, company registration is fine, individuals are not

research use only, handling and analysis, not protocols

retatrutide is not approved anywhere for human use, posts must not read as instructions

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.

Respectfully this is a sample of one presented as a finding.

private 0.25mg is pricing in France this month

triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual

retatrutide is not approved anywhere for human use, posts must not read as instructions